Phcog.Net logo
Submit

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Pharmacognosy MagazineNOW IN
    Article

    The Standardized Extract of Limonium tetragonum Alleviates Chronic Alcoholic Liver Injury in C57BL/6J Mice

    Na-Hyun Kim1, Jeong-Doo Heo2, Jung-Rae Rho2, Min Hye Yang3★, Eun Ju Jeong4★★ Corresponding author

    1. 1Gyeongnam Department of Environment and Toxicology, Korea Institute of Toxicology, Gyeongnam 52834, Republic of Korea.
    2. 2Department of Oceanography, Kunsan National University, Jeonbuk 54150, Republic of Korea.
    3. 3College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.
    4. 4Department of Agronomy and Medicinal Plant Resources, Gyeongnam National University of Science and Technology, Jinju 52725, Republic of Korea.

    CORRESPONDENCE

    Min Hye Yang

    College of Pharmacy, Pusan National University, Busan 46241, Republic of Korea.

    mhyang@pusan.ac.kr

    Received: 06-02-2017; Revised: 14-03-2017; Accepted: 14-03-2017.

    Volume 14, Issue 53 · pp. 58–63 · PUBLISHED 20 February 2018 · DOI: 10.4103/pm.pm_44_17

    View on Pharmacogn. Mag. original site ↗

    ABSTRACT

    Background: In traditional folk medicine, Limonium tetragonum is used in the treatment of uterine hemorrhage, tinnitus, and oligomenorrhea. Objective: This study aimed to identify the therapeutic effect of L. tetragonum EtOAc extract (EALT) on liver of mice with chronic alcohol poisoning. Materials and Methods: C57BL/6J mice were administered 100 mg/kg of EALT with a single binge ethanol/Lieber‑DeCarli liquid diet for 8 weeks. Results: The chronic‑binge ethanol diet induced a significant increase in liver marker enzyme activities. Coadministration of EALT reversed the elevation of serum total cholesterol and triglyceride as well as aspartate aminotransferase and alanine aminotransferase due to chronic alcohol consumption. Histologic findings including markedly attenuated fat accumulation in hepatocytes were observed in EALT‑treated mice. EALT supplementation prevented alcoholic liver injury through attenuation of inflammatory mediators such as toll‑like receptor‑4, cytochrome P4502E1, and cyclooxygenase‑2, and inflammatory cytokine interleukin‑6. Conclusion: Results provided direct experimental evidence for the hepatoprotective effect of EALT in the NIAAA mouse model. Therapeutic attempts with the L. tetragonum extract might be useful in the management of alcoholic liver disease.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Kim, N., Heo, J., Rho, J., Yang, M. H., & Jeong, E. J. (2018). The Standardized Extract of Limonium tetragonum Alleviates Chronic Alcoholic Liver Injury in C57BL/6J Mice. Pharmacognosy Magazine, 14(53), 58–63. https://doi.org/10.4103/pm.pm_44_17